PSORIASI OF THE NAILS IS VERY COMMON, AFFECTING UP TO 80% OF PATIENTS WITH SKIN LESIONS, AND ALSO OCCURRING AS ISOLATED NAIL DISEASE. NAIL PSORIASIS IS MORE COMMON IN PATIENTS WITH SEVERE DISEASE AND IN THOSE WITH PSORIATIC ARTHOPATHY AND IS CONSIDERED BY THE NAIL DYSTROPHIES, AND OFTEN FRUSTATED BY PREVIOUS INEFFECTIVE OR POORLY TOLERATED TREATMENTS. COMBINATION OF TOPICAL DRUGS AND PRODUCTS WITH DIFFERENT MODE OF ACTION AND MODALITY OF APPLICATION IS PROBABLY THE BEST WAY TO OBTAIN IMPROVEMENT OF NAIL PSORIASIS, IN ORDER TO TARGET BOTH NAIL BED AND NAIL MATRIX SYMPTON. THE COMBINED TREATED WITH TOPICAL TAZAROTENE AND UREA CONTANING NAIL LACQUER IS A VALID THERAPEUTIC OPTION IN THESE PATIENTS
BIANCA MARIA PIRACCINI, ., Michela, S., Francesca, B., Aurora, A. (2015). TREATMENT OF NAIL PSORIASIS WITH COMBINATION OF TOPICAL TAZAROTENE AND UREA-CONTAINING NAIL LACQUER: PRELIMINARY EXPERIENCE ON 6 PATIENTS. CLINICAL DERMATOLOGY, 3, 1-6.
TREATMENT OF NAIL PSORIASIS WITH COMBINATION OF TOPICAL TAZAROTENE AND UREA-CONTAINING NAIL LACQUER: PRELIMINARY EXPERIENCE ON 6 PATIENTS
BIANCA MARIA PIRACCINI
;MICHELA STARACE;FRANCESCA BRUNI;AURORA ALESSANDRINI
2015
Abstract
PSORIASI OF THE NAILS IS VERY COMMON, AFFECTING UP TO 80% OF PATIENTS WITH SKIN LESIONS, AND ALSO OCCURRING AS ISOLATED NAIL DISEASE. NAIL PSORIASIS IS MORE COMMON IN PATIENTS WITH SEVERE DISEASE AND IN THOSE WITH PSORIATIC ARTHOPATHY AND IS CONSIDERED BY THE NAIL DYSTROPHIES, AND OFTEN FRUSTATED BY PREVIOUS INEFFECTIVE OR POORLY TOLERATED TREATMENTS. COMBINATION OF TOPICAL DRUGS AND PRODUCTS WITH DIFFERENT MODE OF ACTION AND MODALITY OF APPLICATION IS PROBABLY THE BEST WAY TO OBTAIN IMPROVEMENT OF NAIL PSORIASIS, IN ORDER TO TARGET BOTH NAIL BED AND NAIL MATRIX SYMPTON. THE COMBINED TREATED WITH TOPICAL TAZAROTENE AND UREA CONTANING NAIL LACQUER IS A VALID THERAPEUTIC OPTION IN THESE PATIENTSI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
